Mostrar el registro sencillo del ítem

Artículo

dc.creatorCañada García, Javier E.es
dc.creatorMoure, Zairaes
dc.creatorSola Campoy, Pedro J.es
dc.creatorDelgado-Valverde, Mercedeses
dc.creatorCano, María E.es
dc.creatorGijón, Desiréees
dc.creatorPascual Hernández, Álvaroes
dc.creatorOteo Iglesias, Jesúses
dc.date.accessioned2023-05-11T13:08:29Z
dc.date.available2023-05-11T13:08:29Z
dc.date.issued2022
dc.identifier.citationCañada García, J.E., Moure, Z., Sola Campoy, P.J., Delgado-Valverde, M., Cano, M.E., Gijón, D.,...,Oteo Iglesias, J. (2022). CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3. Frontiers in Microbiology, 13, 918362. https://doi.org/10.3389/fmicb.2022.918362.
dc.identifier.issn1664-302Xes
dc.identifier.urihttps://hdl.handle.net/11441/145863
dc.description.abstractObjectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis. Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were blaOXA−48 (263/377), blaKPC−3 (62/377), blaVIM−1 (28/377), and blaNDM−1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5). Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3.es
dc.formatapplication/pdfes
dc.format.extent13 p.es
dc.language.isoenges
dc.publisherFrontiers Media S.A.es
dc.relation.ispartofFrontiers in Microbiology, 13, 918362.
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCARB-ES-19 studyes
dc.subjectCarbapenemaseses
dc.subjectWhole genome sequencinges
dc.subjectKlebsiella pneumoniaees
dc.subjectHigh-risk cloneses
dc.titleCARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3es
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Microbiologíaes
dc.relation.projectIDPI18CIII/00030 and PI21CIII/00039es
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fmicb.2022.918362/fulles
dc.identifier.doi10.3389/fmicb.2022.918362es
dc.contributor.groupUniversidad de Sevilla. CTS210: Resistencia a antimicrobianos.es
dc.journaltitleFrontiers in Microbiologyes
dc.publication.volumen13es
dc.publication.initialPage918362es
dc.contributor.funderInstituto de Salud Carlos IIIes
dc.contributor.funderMinisterio de Economía y Competitividad (MINECO). Españaes

FicherosTamañoFormatoVerDescripción
Carbapenemase Producing.pdf3.725MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Atribución 4.0 Internacional